14-92135387-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001322271.2(CPSF2):c.-24A>G variant causes a 5 prime UTR premature start codon gain change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000273 in 1,613,488 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001322271.2 5_prime_UTR_premature_start_codon_gain
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CPSF2 | NM_017437.3 | c.436A>G | p.Ile146Val | missense_variant | Exon 6 of 16 | ENST00000298875.9 | NP_059133.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CPSF2 | ENST00000298875.9 | c.436A>G | p.Ile146Val | missense_variant | Exon 6 of 16 | 1 | NM_017437.3 | ENSP00000298875.4 | ||
CPSF2 | ENST00000554290.1 | n.*87A>G | non_coding_transcript_exon_variant | Exon 5 of 5 | 4 | ENSP00000452503.1 | ||||
CPSF2 | ENST00000554290.1 | n.*87A>G | 3_prime_UTR_variant | Exon 5 of 5 | 4 | ENSP00000452503.1 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152222Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000359 AC: 9AN: 250754Hom.: 0 AF XY: 0.0000516 AC XY: 7AN XY: 135536
GnomAD4 exome AF: 0.0000246 AC: 36AN: 1461148Hom.: 0 Cov.: 30 AF XY: 0.0000289 AC XY: 21AN XY: 726894
GnomAD4 genome AF: 0.0000525 AC: 8AN: 152340Hom.: 0 Cov.: 33 AF XY: 0.0000805 AC XY: 6AN XY: 74496
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.436A>G (p.I146V) alteration is located in exon 6 (coding exon 4) of the CPSF2 gene. This alteration results from a A to G substitution at nucleotide position 436, causing the isoleucine (I) at amino acid position 146 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at